Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Productos biológicos, colchicina, corticosteroides, inmunosupresores e interferón alfa para el síndrome neuro‐Behçet

Información

DOI:
https://doi.org/10.1002/14651858.CD010729.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 diciembre 2014see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Esclerosis múltiple y enfermedades raras del sistema nervioso central

Copyright:
  1. Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Francesca Nava

    Faculty of Statistical Science, University of Milano‐Bicocca, Milan, Italy

  • Francesca Ghilotti

    Faculty of Statistical Science, University of Milano‐Bicocca, Milan, Italy

  • Lorenzo Maggi

    Neurology IV‐ Neuro‐Immunology and Neuromuscular Diseases, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy

  • Gulen Hatemi

    Department of Internal Medicine, Division of Rheumatology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey

  • Alessandra Del Bianco

    Department of Rheumatology, AOUP, Pisa, Italy

  • Chiara Merlo

    Ospedale Di Circolo Del Ponte, Fondazione Marchi, Varese, Italy

  • Graziella Filippini

    Scientific Direction, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy

  • Irene Tramacere

    Correspondencia a: Neuroepidemiology Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy

    [email protected]

Contributions of authors

Concept ‐ GF, IT

Title registration ‐ GF, IT, FN, FG

Protocol draft ‐ GF, IT, FN, FG

Protocol editing ‐ GF, IT

Data abstraction ‐ FN, FG

Data entry ‐ FN, FG

Drafting the review ‐ IT, LM

Editing and revising the review ‐ GF, IT, LM, GH, ADB, CM

Sources of support

Internal sources

  • Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Milano, Italy.

    Support the editorial base of "Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group"

External sources

  • Protocol submitted to the independent research programme of the Italian Medicines Agency (AIFA), Italy.

    Financially support the reviewers

Declarations of interest

FN ‐ none

FG ‐ none

LM ‐ none

GH ‐ none

ADB ‐ none

CM ‐ none

GF ‐ none

IT ‐ none

Acknowledgements

We thank Peter Tugwell and Richard Wormald for useful comments during the preparation of the manuscript.

We thank Andrea Fittipaldo, Trials Search Co‐ordinator of the Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group, for her help and support in developing this review.

We thank Yoshifumi Tada (Department of Rheumatology, Faculty of Medicine, Saga University, Saga, Japan), and Corynne Marchal (Managing Editor ‐ Cochrane Lung Cancer Group, Besancon University Hospital ‐ University of Franche‐Comte, CHRU Besançon, France ‐ Service Pneumologie) for having read and extracted data from original articles.

Version history

Published

Title

Stage

Authors

Version

2014 Dec 18

Biologics, colchicine, corticosteroids, immunosuppressants and interferon‐alpha for Neuro‐Behçet's Syndrome

Review

Francesca Nava, Francesca Ghilotti, Lorenzo Maggi, Gulen Hatemi, Alessandra Del Bianco, Chiara Merlo, Graziella Filippini, Irene Tramacere

https://doi.org/10.1002/14651858.CD010729.pub2

2013 Sep 05

Biologics, colchicine, corticosteroids, immunosuppressants and interferon‐alpha for Neuro‐Behçet's Syndrome

Protocol

Francesca Nava, Francesca Ghilotti, Gulen Hatemi, Alessandra Del Bianco, Chiara Merlo, Graziella Filippini, Irene Tramacere

https://doi.org/10.1002/14651858.CD010729

Differences between protocol and review

None.

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Flow diagram.
Figuras y tablas -
Figure 1

Flow diagram.

Flow diagram (2).
Figuras y tablas -
Figure 2

Flow diagram (2).